Back

The influence of the standard heart failure treatment on the RDW variation in patients with decompensated heart failure

21 May 2016 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 4 - Biomarkers Biomarkers, other HFA Premium Access HEART FAILURE 2016

About the speaker

Photo
Assistant Professor Raluca Ianula Ciomag

Bagdasar-Arseni Emergency Hospital, Bucharest (Romania)

16 More presentations in this session

Presentation thumbnail
The association of galectin-3 and clinical parameters in patients with chronic heart failure
Doctor K. Gyamdjyan (Moscow, RU)
Presentation thumbnail
Association between neutrophil gelatinase-associated lipocalin (NGAL) and ventricular function in patients with chagas cardiomyopathy. Nephron or cardiomyocyte?
Doctor L. Echeverria (Floridablanca, CO)
Abstract Slides
Presentation thumbnail
Low circulating microRNA levels in heart failure patients are associated with peripheral arterial disease
Doctor E. Vegter (Groningen, NL)
Abstract Slides
Presentation thumbnail
Influence of body mass index on laboratory and biomarkers in acute heart failure patients
Doctor K. Streng (Groningen, NL)
Abstract Slides
Presentation thumbnail
The role of circulating miR-21, miR-34a, miR-423, miR-208a and miR-499a in ischemic and dilated cardiomyopathy
Professor I. Zhirov (Moscow, RU)
Abstract

Access the full session

Session thumbnail
Poster Session 4 - Biomarkers

The Event

Event poster

HEART FAILURE 2016

21 May - 24 May 2016

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources